What is MS (Multiple Sclerosis)?

Multiple sclerosis (MS) is an autoimmune disorder characterized by destruction of myelin in the central nervous system. MS symptoms may include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction.

What is it like to have MS?

Common symptoms How bad it is What people are taking for it
Severity
Severe
Moderate
Mild
None
Modafinil, Donepezil, Ginkgo Biloba
Naps, Armodafinil, Modafinil
Amantadine, Handicap/Disability Parking Permit, Modafinil
Tizanidine, Walking Stick/Cane, Baclofen
Oxybutynin, Tolterodine, Solifenacin
Gabapentin, Ibuprofen, Hydrocodone-Acetaminophen
Duloxetine, Bupropion, Fluoxetine
Fluoxetine, Escitalopram, Lamotrigine
Polyethylene Glycol 3350, Stool Softener, Fiber supplement
Amitriptyline, Zolpidem, Trazodone
Listen to Music, Sertraline, Citalopram
Alprazolam, Clonazepam, Lorazepam
Sildenafil, Tadalafil, Vardenafil

What do patients take to treat MS and its symptoms?

Treatments reported by members Perceived effectiveness Overall rating of side effects # of Evaluations
(Copaxone)
1493
(Avonex Pen, Avonex Prefilled Syringe, Avonex)
848
773
(Tysabri, Antegren)
580
(Extavia, Betaseron, Betaferon, Uribeta)
426
(DOM-Baclofen, Stelax, Mylan Baclofen, Spinax)
200
(Wockhardt Methylprednisolone, Medrol DosePak, Medrol, Advantan)
174
(ReVia, Low Dose Naltrexone (LDN))
171
163
(Gilenya)
137
(Modavigil, Modiodal, Alertec, Provigil)
102
(Pulmison, Prednisone Intensol, Encorton, Deltasone)
76
(Twin Labs Vitamin D, Country Life Vitamin D, Biocare Vitamin D, Vitacost Vitamin D)
65
(Novantrone)
57
51

These charts show data from MS patients' latest treatment evaluations

Who has MS at PatientsLikeMe?

<20 20s 30s 40s 50s 60s 70+
Current Age
Distribution of females vs. males
Gender
80% Females
20% Males
Age at first symptom
Age at first symptom # of patients Proportion
0-19 years 1,922
20-29 years 6,677
30-39 years 6,969
40-49 years 4,128
50-59 years 988
60-69 years 71
70+ years 9
Types
Condition Types # of patients Proportion
Primary Progressive 1,768
Progressive Relapsing 807
Relapsing-Remitting 17,161
Secondary Progressive 2,834
Diagnosis status
Diagnosis status # of patients Proportion
Not Diagnosed 976
Diagnosed 23,196

These charts show data from MS patients who have completed their condition history